雷洛昔芬在治疗相关浓度下通过依赖钙的内皮型一氧化氮合酶激活舒张加压大鼠阻力血管。
Therapeutically relevant concentrations of raloxifene dilate pressurized rat resistance arteries via calcium-dependent endothelial nitric oxide synthase activation.
机构信息
Institute of Vascular Medicine, Hong Kong, China.
出版信息
Arterioscler Thromb Vasc Biol. 2010 May;30(5):992-9. doi: 10.1161/ATVBAHA.110.203935. Epub 2010 Feb 25.
OBJECTIVE
Selective estrogen receptor modulators (SERMs) inhibit constriction of mammalian conduit arteries. However, it is unknown whether SERMs at therapeutically achievable concentrations could reduce vascular tone in resistance arteries. The present study aimed to examine roles of Ca(2+) influx in endothelium and endothelial nitric oxide synthase (eNOS) activation in dilatations induced by raloxifene, a second-generation SERM in myogenically active arteries.
METHODS AND RESULTS
Small mesenteric arteries from Sprague-Dawley rats were isolated and mounted in a pressure myograph for measurement of changes in vessel diameter. Ca(2+) images on native endothelial cells of intact arteries were determined by the fluorescence imaging technique, and phosphorylation of eNOS was assayed by Western blotting. Raloxifene (0.3 to 10 nmol/L) produced dilatations on established steady myogenic constriction. Female rat arteries dilated significantly more in response to raloxifene than male arteries. Raloxifene-induced dilatations of female arteries were blunted by N(G)-nitro-l-arginine methyl ester but unaffected by 1400W, charybdotoxin plus apamin, wortmannin, or LY294002. Raloxifene (3 nmol/L) triggered rises in endothelial cell Ca(2+) and increased eNOS phosphorylation at Ser1177. Both effects were greater in arteries from female rats than in arteries from male rats. Increases in endothelial cell Ca(2+) and in eNOS phosphorylation were prevented by removal of extracellular Ca(2+) ions. Finally, ICI 182,780 did not affect the raloxifene-stimulated rise in endothelial cell Ca(2+), eNOS phosphorylation, and vasodilatations. Chronic raloxifene treatment reduced myogenic constriction in arteries from female but not male rats.
CONCLUSION
Raloxifene at therapeutically relevant concentrations inhibits myogenic constriction by an NO-dependent mechanism that causally involves the elevated Ca(2+) in endothelial cells and subsequent eNOS activation. Raloxifene dilates resistance arteries more effectively in female rats, indicating its significant gender-related action on endothelial cells in microcirculation.
目的
选择性雌激素受体调节剂(SERM)可抑制哺乳动物导管动脉的收缩。然而,尚不清楚在治疗上可达到的浓度下,SERM 是否可以降低阻力动脉的血管张力。本研究旨在探讨钙内流在雷洛昔芬诱导的肌源性活性动脉舒张中的作用,雷洛昔芬是第二代 SERM。
方法和结果
从小鼠肠系膜分离出小动脉并安装在压力肌动描记器上,以测量血管直径的变化。通过荧光成像技术测定完整动脉内皮细胞的[Ca2+]i 图像,并通过 Western blot 测定 eNOS 的磷酸化。雷洛昔芬(0.3 至 10 nmol/L)在已建立的稳定肌源性收缩时产生舒张作用。雌性大鼠的动脉对雷洛昔芬的舒张作用明显大于雄性大鼠。N(G)-硝基-L-精氨酸甲酯可阻断雷洛昔芬诱导的雌性大鼠动脉舒张,但 1400W、蟾毒碱加阿帕米、wortmannin 或 LY294002 对其无影响。雷洛昔芬(3 nmol/L)可引发内皮细胞[Ca2+]i 的升高,并增加 Ser1177 处的 eNOS 磷酸化。这些作用在雌性大鼠的动脉中比在雄性大鼠的动脉中更为明显。去除细胞外 Ca2+离子可阻止内皮细胞[Ca2+]i 的增加和 eNOS 磷酸化。最后,ICI 182780 不影响雷洛昔芬刺激的内皮细胞[Ca2+]i 升高、eNOS 磷酸化和血管舒张。慢性雷洛昔芬治疗可降低雌性大鼠但不降低雄性大鼠的血管肌源性收缩。
结论
在治疗相关浓度下,雷洛昔芬通过一种 NO 依赖性机制抑制肌源性收缩,该机制涉及内皮细胞中升高的[Ca2+]i 和随后的 eNOS 激活。雷洛昔芬在雌性大鼠中更有效地舒张阻力动脉,表明其对微血管内皮细胞具有显著的性别相关作用。